These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 627136)

  • 21. [Connection between the kinetics and the therapeutic effects of tricyclic antidepressive agents. A review and results obtained with nortriptyline (Sensival)].
    Kragh-Sorensen P
    Ugeskr Laeger; 1972 Oct; 134(44):2309-14. PubMed ID: 5087288
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma nortriptyline and clinical response.
    Burrows G; Scoggins BA; Turecek LR; Davies B
    Clin Pharmacol Ther; 1974 Oct; 16(4):639-44. PubMed ID: 4608523
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma-nortriptyline levels in endogenous depression.
    Kragh-Sørensen P; Asberg M; Eggert-Hansen C
    Lancet; 1973 Jan; 1(7795):113-5. PubMed ID: 4118463
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term treatment of endogenous depression with nortriptyline with control of plasma levels.
    Kragh-Sorensen P; Hansen CE; Larsen NE; Nasestoft J; Hvidberg EF
    Psychol Med; 1974 May; 4(2):174-80. PubMed ID: 4208380
    [No Abstract]   [Full Text] [Related]  

  • 25. Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline.
    Asberg M; Bertilsson L; Tuck D; Cronholm B; Sjöqvist F
    Clin Pharmacol Ther; 1973; 14(2):277-86. PubMed ID: 4695388
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationship between antidepressant effect and plasma level of nortriptyline. Clinical studies.
    Kragh-Søorensen P; Hansen CE; Baastrup PC
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):27-32. PubMed ID: 790409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic control of plasma concentrations and long-term effect of nortriptyline in recurrent affective disorders.
    Kragh-Sørensen ; Hansen CE; Baastrup PC; Hvidberg EF
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):178-82. PubMed ID: 981330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients.
    Jungkunz G; Kuss HJ
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):111-6. PubMed ID: 7393997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers.
    Dawling S; Crome P; Braithwaite R
    Clin Pharmacokinet; 1980; 5(4):394-401. PubMed ID: 6994983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma nortriptyline levels--relationship to clinical effects.
    Asberg M
    Clin Pharmacol Ther; 1974 Jul; 16(1):215-29. PubMed ID: 4602067
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels - a review of routine practice.
    Jessurun N; van Puijenbroek EP; Otten LS; Mikes O; Vermeulen Windsant A; van Marum RJ; Grootens K; Derijks HJ
    Br J Clin Pharmacol; 2017 May; 83(5):1149-1151. PubMed ID: 28133768
    [No Abstract]   [Full Text] [Related]  

  • 32. The practical significance of nortriptyline plasma control. A prospective evaluation under routine conditions in endogenous depression.
    Sørensen B; Kragh-Sørensen P; Larsen NE; Hvidberg EF
    Psychopharmacology (Berl); 1978 Sep; 59(1):35-9. PubMed ID: 100810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and erythrocyte levels of tricyclic antidepressants in depressed patients.
    Linnoila M; Dorrity F; Jobson K
    Am J Psychiatry; 1978 May; 135(5):557-61. PubMed ID: 347952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation of subjective side-effects with plasma concentrations of nortriptyline.
    Asberg M
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):20. PubMed ID: 5314406
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical significance of plasma levels of tricyclic antidepressant drugs in the treatment of depression.
    Lancet; 1973 Mar; 1(7802):556-8. PubMed ID: 4119995
    [No Abstract]   [Full Text] [Related]  

  • 36. Implications of dose regimen and protein binding for plasma nortriptyline estimations.
    Stevenson IH; Wilson NM; Schiff AA
    Neuropharmacology; 1978 Jun; 17(6):423-6. PubMed ID: 673158
    [No Abstract]   [Full Text] [Related]  

  • 37. Dosage adjustment from simple nortriptyline spot level predictor tests in depressed patients.
    Montgomery SA; McAuley R; Montgomery DB; Braithwaite RA; Dawling S
    Clin Pharmacokinet; 1979; 4(2):129-36. PubMed ID: 378500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relation of plasma amitriptyline and nortriptyline levels to the therapeutic response in endogenous depression].
    Garaj V; Frank V; Drímalová M; Móric R; Pullmann R
    Cesk Psychiatr; 1986 Oct; 82(5):307-12. PubMed ID: 3791462
    [No Abstract]   [Full Text] [Related]  

  • 39. A simplified radioimmunoassay of plasma nortriptyline in depressed patients compared with high-pressure liquid chromatography and gas-liquid chromatography.
    Sayegh JF
    Neurochem Res; 1986 Feb; 11(2):193-206. PubMed ID: 3703101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pharmacokinetic approach to the treatment of depression.
    Sjöqvist F
    Int Pharmacopsychiatry; 1971; 6(3):147-69. PubMed ID: 4950568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.